Global Automated And Closed Cell Therapy Processing Systems Market Growth (Status and Outlook) 2025-2031

The global Automated And Closed Cell Therapy Processing Systems market size is predicted to grow from US$ 1152 million in 2025 to US$ 3627 million in 2031; it is expected to grow at a CAGR of 21.1% from 2025 to 2031.

Automated and closed cell therapy processing systems are specialized technologies used in the field of regenerative medicine and cell therapy. These systems refer to the use of automated technology and equipment to perform various steps involved in the manufacturing and processing of cell-based therapies. This includes processes such as cell isolation, expansion, culture, harvesting, and quality control. Automation aims to reduce variability, improve reproducibility, and enhance the efficiency of cell therapy production. By automating these processes, it becomes possible to achieve higher throughput, maintain sterility, and ensure consistency in the final product. Closed systems in cell therapy processing refer to the use of fully enclosed environments and devices that minimize the exposure of cells to the external environment throughout the manufacturing process. Closed systems are critical for maintaining the safety and quality of cell therapies by reducing the risk of microbial contamination and protecting the cells from exposure to harmful agents.

North America is the largest Automated and Closed Cell Therapy Processing Systems market, which has a share about 41%, followed by Asia-Pacific and Europe with a market share of 34% and 24%, respectively. In terms of product type, Non-Stem Cell Therapy is the largest segment, occupied for a share of 90%. And in terms of application, Industry is the largest segment, which has a share about 66%.

LPI (LP Information)' newest research report, the “Automated And Closed Cell Therapy Processing Systems Industry Forecast” looks at past sales and reviews total world Automated And Closed Cell Therapy Processing Systems sales in 2024, providing a comprehensive analysis by region and market sector of projected Automated And Closed Cell Therapy Processing Systems sales for 2025 through 2031. With Automated And Closed Cell Therapy Processing Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Automated And Closed Cell Therapy Processing Systems industry.

This Insight Report provides a comprehensive analysis of the global Automated And Closed Cell Therapy Processing Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Automated And Closed Cell Therapy Processing Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Automated And Closed Cell Therapy Processing Systems market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Automated And Closed Cell Therapy Processing Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Automated And Closed Cell Therapy Processing Systems.

This report presents a comprehensive overview, market shares, and growth opportunities of Automated And Closed Cell Therapy Processing Systems market by product type, application, key players and key regions and countries.

Segmentation by Type:

Stem Cell Therapy

Non-Stem Cell Therapy

Segmentation by Application:

Academia

Industry

This report also splits the market by region:

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

Cytiva

Miltenyi Biotec

Thermo Fisher Scientific

Terumo

Merck

Fresenius Kabi

Sartorius

Lonza

Boyalife (ThermoGenesis)

EurekaBio

Please note: The report will take approximately 2 business days to prepare and deliver.